Skip to main content
. 2017 May 3;96(5):1117–1123. doi: 10.4269/ajtmh.16-0904

Table 1.

Formulations of antimalarial medicines of varying brands and manufacturers tested using NIR spectroscopy

SAPI Brand name Manufacturer Country
Artemether–lumefantrine Alu Ipca India
Artefan Ajanta India
Artemef Cipla India
Coartem Novartis China and United States
Coatal Jiangsu Yixing China
Cofantrine Bliss GVS India
Colart Ipca India
Combisunate Ajanta India
Lonart-Ds Bliss GVS India
Lufanter Bliss GVS India
Lumartem/LumArt + Cipla India
Tamether Fort Jiangsu Yixing China
Artesunate monotherapy Actitesunate Jiangsu China
Adamsnate Adams China
Artesunat Mekophar Vietnam
Artesunate 50 Aurochem India
Artesunate Tabs Guilin China
Cusnat Artesunate Green Energy China
Gricin Greenfield Chain
Lever Artesunate Adams China
Artesunate–amodiaquine Adamsnate Plus Adams China
Arsuamoon Guilin China
Art Amo Adult Ipca India
ArtAm Guilin China
Arthesis + Cipla India
Asaq-Denk Artesan Germany
Malatex Kinapharma Ghana
Winthrop Maphar Morocco
Artesunate–sulfamethoxypyrazine–pyrimethamine Co-Arinate Famar Italia Italy
Malafan Plus Kinapharma Ghana
Dihydroartemisinin–piperaquine Waipa Act Kunimed Nigeria

NIR = near-infrared; SAPI = stated active pharmaceutical ingredient.